67,151 new cases, 1,059 deaths take India’s Covid-19 caseload to 32,34,474 and toll to 59,449, the heath ministry said. While the government also said that with positivity rate progressively falling, testing has worked as an effective tool to limit the spread of Covid-19 infection.
With 1,066 fatalities reported on Tuesday, the country’s death toll is nearing 60,000 – only a notch below Mexico’s toll (60,800). Five most affected states by total tally of cases are Maharashtra (703,823), Tamil Nadu (391,303), Andhra Pradesh (371,639), Karnataka (291,826), and Uttar Pradesh (197,000). Delhi recorded 1,544 fresh Covid-19 cases, taking tally to 1,64,071.
Fresh guidelines for Unlock 4.0 are expected to be announced in the coming days. The Metro service in Delhi NCR, suspended since March 22 in the wake of the outbreak, is likely to resume in September, an official of the Ministry of Home Affairs said.
Trials for the Oxford University’s vaccine, developed in collaboration with AstraZeneca, will begin in India on Wednesday. Six volunteers will be administered doses at Pune’s Bharati Vidyapeeth medical college and hospital. This is phase-2 of the trial, as it is not mandatory to conduct phase-1 trials in India, where the vaccine’s safety is assessed.
As many as 24,042,682 people around the world have been diagnosed with Covid-19. While more than 16,591,338 have recovered, 822,499 have died so far. The US, the worst-hit country, has 5,954,810 cases. It is followed by Brazil, which has 3,674,176.
Delhi Chief Minister Arvind Kejriwal will hold a meeting with senior officials at 11 am this morning to discuss the increase in Covid-19 cases in the national capital and positivity rate.
The Russian government has reached out to India seeking a collaboration for manufacturing its COVID-19 vaccine Sputnik V’ and conducting its phase 3 clinical trial here, reports said. The matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22, it is said.